| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2515.43 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2403.51 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 1620.21 | 97 |
| GSM780719 | Untreated after 4 days (C1_2) | 2524.38 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2553.32 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 1660.4 | 97 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1694.41 | 97 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2500.38 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2102.3 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 2042.44 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2629.57 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2245.94 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2288.89 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2579.22 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2321.69 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2490.79 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2460.15 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2394.89 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 3105.04 | 99 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2629.57 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2434.25 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 3128.15 | 99 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2907.34 | 99 |